Brecon Burgopak Kalms cropped

For the launch of its new Kalms Day tablet, Lanes Health was looking for a packaging services partner that could both provide an innovative packaging solution for its range extension, as well as manage the whole packaging and logistics operation on their behalf. The Burgopak slider was chosen to package the new Kalms Day tablets as it delivers a compact solution that conveniently retains the patient information and blisters, while being durable, engaging and making all components easily accessible.

Brecon Pharmaceuticals operates the only Burgopak production line in Europe and has extensive expertise in contract packing, storage and distribution. The company became the obvious choice for Lanes Health and its Kalms Day product.

Packaging of the Kalms Day tablets into the Burgopaks started in July 2011 at Brecon's Hay-on-Wye facility, with the Brecon and Lanes Health teams working closely together to manage an extremely tight production schedule and ensure that the new product was on retail shelves by early September.

Hilary Lynn, senior product manager at Lanes Health, says, "It was essential to have a seamless production process, which in this case, meant working closely with Brecon Pharmaceuticals. All the team at Brecon were extremely responsive and kept us fully informed of developments throughout the process and worked quickly to ensure any production challenges were overcome and our crucial launch date was met.

"The combination of the innovative Burgopak and Brecon's management of the packaging and logistical process has been the perfect solution for us," continues Lynn.

"Traditionally, the Kalms product range is packaged in glass bottles and standard blister packs. However this latest range extension required a completely different packaging approach. It was vital that we maintained our brand image, while presenting our product in a highly portable and durable format that would stand up to the wear and tear of being carried around in bags or pockets.

"We're delighted with the end product and, although it's still early days, trade interest is very positive and consumer sales are growing steadily," concludes Lynn.

Source: Brecon Pharmaceuticals

.